2024 年至 2031 年肩關節置換市場（依手術類型、植入物設計、植入物材料及地區劃分）

肩關節置換市場評估，2024 年至 2031 年

個人和政府增加醫療支出使得先進的醫療服務更實惠。擴大保險覆蓋範圍和報銷指南正在增加患者接受肩關節置換手術的機會，有助於推動市場擴張。因此，醫療保健支出的增加正在加速市場規模的成長，到 2024 年市場規模將超過 19.5 億美元，到 2031 年將達到 33 億美元的估值。

肥胖、久坐等生活型態因素導致骨關節炎等肩關節疾病的流行。肥胖尤其會對關節造成額外的壓力，加速關節退化並增加肩關節置換手術的需要。因此，肥胖和久坐的生活方式將推動市場在 2024 年至 2031 年期間以 7.50% 的複合年增長率成長。

肩關節置換市場定義/概述

肩關節置換術是一種外科手術，其中用人工關節部件（通常稱為植入物）替換肩關節中的骨骼。此手術可能是部分的或完全的，取決於肩關節損傷的程度。肩關節置換手術中使用的人工植入物通常由金屬和聚乙烯製成。事實證明，肩關節置換手術是一種有效的治療方法，適用於患有骨關節炎和其他使人衰弱的肩部疾病的患者，尤其是在非手術治療失敗的情況下。

全肩關節置換術是一種成熟的外科手術，旨在恢復關節炎肩部的舒適度和功能。在這次手術中，肩關節的球被一個光滑的金屬球取代，該金屬球通過一個適合骨頭的柄連接到手臂骨（肱骨）。以高密度聚乙烯製成的人工關節重新修復患處的關節窩（關節盂）。在現有的各種外科手術中，肩關節置換手術能最迅速、最全面地改善關節炎肩關節的舒適度和功能。

肩關節置換手術的成功在很大程度上取決於手術的技術準確性以及患者對旨在實現所需運動範圍的術後運動計畫的堅持。透過遵循結構化的復健計劃，患者可以最大限度地享受手術的好處，顯著緩解疼痛，並明顯改善肩部活動能力。總體而言，肩關節置換手術對於患有嚴重肩關節問題的人來說是一種非常有效的治療方法，透過改善關節功能提供新的生活品質。

老年人口的增加和肩關節損傷發生率的提高將如何推動肩關節置換市場的成長？

全球老齡人口的不斷增加對肩關節置換市場有利。隨著人們壽命的延長，與年齡相關的肩部疾病（如類風濕性關節炎和骨關節炎）變得越來越普遍。易患肩關節退化的長者越來越需要肩關節置換手術來控制疼痛和恢復活動能力。由於創傷、身體活動和工作相關風險以及與年齡相關的狀況而導致的肩部損傷發生頻率增加促進了市場的成長。這些損傷常常導致慢性疼痛和功能喪失，需要肩關節置換手術來恢復關節功能並緩解不適。例如

美國國家衛生統計中心

在美國，成年人上肢疼痛的盛行率隨著年齡的增長而增加，從18-29歲族群的16.2％上升到30-44歲族群的24.1％。45歲至64歲族群的數字達到37.9％，而65歲及以上族群的數字達到42.0％。

植入技術的進步也促進了肩關節置換市場的成長。植入物設計、材料和手術技術的不斷創新可改善治療效果並提高患者滿意度。現代植入物具有更高的穩定性、更長的壽命和更大的活動範圍，使得肩關節置換術更有效、對患者更具吸引力。此外，患者對肩關節置換手術益處的認知也越來越高。隨著人們越來越積極地尋求治療肩部功能障礙和疼痛，對這些手術的需求也日益增長。越來越多的患者意識到肩關節置換手術可以顯著改善活動能力、減輕疼痛並提高整體生活品質。

手術工具和器械的技術進步也促進了肩關節置換市場的成長。機器人輔助手術、導航系統和手術器械的創新正在提高肩關節置換手術的精確度和準確性。這些技術使外科醫生能夠執行微創手術，從而減少組織損傷並加快恢復時間，從而提高患者對這些手術的接受度和採用率。醫療保健基礎設施的擴張，尤其是在新興國家，進一步推動了市場成長。醫療設施的改善、熟練醫務人員數量的增加以及醫療費用的上漲使得人們能夠更多地獲得先進的醫療治療，包括肩關節置換手術。

肩關節置換手術的高成本以及感染和血栓的風險如何阻礙肩關節置換市場的成長？

肩關節置換手術是一項昂貴的手術，其費用不僅包括植入物本身。患者面臨住院、手術費、康復、止痛藥等大量費用，這可能是一個沉重的經濟負擔，特別是對於那些保險覆蓋有限的人來說。例如，在Hyderabad，肩關節置換手術的平均費用一般在 300 萬盧比至 80 萬盧比之間。費用的差異取決於多種因素，包括手術類型、症狀的嚴重程度、醫院設施的品質以及外科醫生的熟練程度。儘管有潛在的好處，但任何手術（包括肩關節置換術）的固有風險和併發症可能會讓一些患者望而卻步。這些風險包括感染、血栓、神經損傷和植入物鬆動，這些風險可能會影響手術的成功並導致進一步的醫療干預。

此外，儘管肩部置換術在許多情況下顯示出良好的效果，但關於植入物的耐久性和各種手術技術的有效性的長期數據仍然有限。缺乏全面的長期證據給患者和外科醫生帶來了不確定性，影響了決策過程。此外，肩關節置換手術並不適合所有人。潛在的市場規模有限，因為年齡、整體健康狀況和關節損傷的嚴重程度等因素在確定手術指徵方面起著關鍵作用。

疼痛管理、物理治療和非手術治療（如可的松注射）可以緩解一些肩痛患者疼痛。這些選擇可以延遲甚至消除手術介入的需要，進一步影響肩關節置換手術的需求。此外，肩關節置換手術的成功在很大程度上取決於嚴格的復健計劃。手術後，患者必須接受專門的物理治療以恢復力量、活動能力和活動範圍。如此廣泛的復健需求可能是一個重大障礙，特別是對於那些難以堅持康復或接受持續物理治療的患者來說。

目錄

第 1 章 簡介

• 市場定義
• 市場細分
• 調查方法

第 2 章 執行摘要

• 主要發現
• 市場概況
• 市集亮點

第3章 市場概況

• 市場規模和成長潛力
• 市場趨勢
• 市場驅動力
• 市場制約因素
• 市場機會
• 波特五力分析

第4章 肩關節置換術市場（依手術類型劃分）

• 全肩關節置換術 (TSA)
• 部分肩關節置換術（半關節置換術）

第5章 肩關節置換市場（依植入物設計）

• 解剖肩關節置換術
• 反肩關節置換術

第6章 肩關節置換市場（依植入材料）

• 金屬植入物
• 聚乙烯植入物

第7章 區域分析

• 北美
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東/非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合酋長國

第 8 章 市場動態

• 市場驅動力
• 市場制約因素
• 市場機會
• COVID-19 的市場影響

第9章 競爭格局

• 大公司
• 市場佔有率分析

第10章 公司簡介

• Johnson & Johnson
• Stryker Corporation
• Zimmer Biomet
• Exactech
• Waldemar Link GmbH & Co. KG
• Arthrex, Inc.
• Aesculap AG（subsidiary of B. Braun SE）
• DJO Global, Inc.
• Osteonics Corporation

第11章市場前景與機遇

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 縮寫表
• 來源和參考文獻

Shoulder Replacement Market Valuation - 2024-2031

Rising healthcare spending by both individuals and governments is making sophisticated medical treatments more affordable. Expanded insurance coverage and reimbursement guidelines are increasing patient access to shoulder replacement surgeries, propelling market expansion. Thus, increasing healthcare spending is surging the growth of market size surpassing USD 1.95 Billion in 2024 to reach a valuation of USD 3.3 Billion by 2031.

Lifestyle factors such as obesity and sedentary lifestyles are contributing to the prevalence of shoulder conditions like osteoarthritis. Obesity, in particular, places additional stress on joints, accelerating joint deterioration and the need for shoulder replacement surgery. Thus, obesity and sedentary lifestyles are enabling the growth of market to grow at aCAGR of 7.50% from 2024 to 2031.

Shoulder Replacement Market: Definition/ Overview

Shoulder replacement surgery involves substituting the bones of the shoulder joint with artificial joint components, commonly referred to as implants. This procedure can be performed either partially or completely, depending on the extent of damage to the glenohumeral joint. The prosthetic implants used in shoulder replacement are typically composed of metal and polyethylene. Shoulder joint replacement has proven to be an effective treatment for individuals suffering from osteoarthritis and other debilitating shoulder conditions, especially when nonsurgical treatments have failed to provide relief.

Total shoulder replacement arthroplasty is a well-established surgical procedure aimed at restoring comfort and function to an arthritic shoulder. During this surgery, the arthritic ball of the shoulder joint is replaced with a smooth metal ball that is fixed to the arm bone (humerus) using a stem that fits within the bone. The arthritic socket (glenoid) is resurfaced with a high-density polyethylene prosthesis. Among the various surgical options available, total shoulder replacement offers the most rapid and comprehensive improvement in both comfort and function for shoulders affected by arthritis.

The success of shoulder replacement surgery relies heavily on the technical precision of the procedure and the patient's commitment to a postoperative exercise program designed to achieve the desired range of motion. By following a structured rehabilitation plan, patients can maximize the benefits of the surgery, attaining significant relief from pain and a marked improvement in shoulder mobility. Overall, shoulder replacement surgery stands out as a highly effective intervention for those struggling with severe shoulder joint issues, offering a renewed quality of life through enhanced joint functionality.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How do the Rising Geriatric Population and Increasing Frequency of Shoulder Injuries Surge the Growth of the Shoulder Replacement Market?

The increasing aging population globally acts as a boon for the shoulder replacement market. As people live longer, age-related shoulder disorders such as rheumatoid arthritis and osteoarthritis become more prevalent. Older adults, who are more susceptible to shoulder joint degeneration, increasingly require shoulder replacement surgeries to manage pain and restore mobility. In addition to age-related conditions, the rising frequency of shoulder injuries due to trauma, sports activities, and work-related risks is contributing to market growth. These injuries often lead to chronic pain and functional impairment, necessitating shoulder replacement surgery to restore joint function and alleviate discomfort. For instance, according to the

National Center for Health Statistics

, in the United States, the prevalence of upper limb pain among adults increases with age, rising from 16.2% in the 18-29 age group to 24.1% among those aged 30-44. This percentage further increases to 37.9% for individuals aged 45-64 and reaches 42.0% for those aged 65 and older.

Advancements in implant technology are also contributing to the growth of the shoulder replacement market. Continuous innovation in implant design, materials, and surgical techniques has led to improved outcomes and higher patient satisfaction. Modern implants offer better stability, longevity, and range of motion, making shoulder replacement surgeries more effective and appealing to patients. Furthermore, there is a growing awareness among patients about the benefits of shoulder replacement surgeries. As people become more proactive in seeking treatment for shoulder dysfunction and pain, the demand for these procedures is increasing. Patients are increasingly aware that shoulder replacement surgeries can significantly improve mobility, reduce pain, and enhance overall quality of life.

Technological advancements in surgical tools and instruments have also contributed to the growth of the shoulder replacement market. Innovations in robotic-assisted surgery, navigation systems, and surgical instruments have enhanced the precision and accuracy of shoulder replacement procedures. These technologies enable surgeons to perform minimally invasive surgeries, which result in less tissue damage and quicker recovery times, thereby increasing patient acceptance and adoption of these procedures. The expansion of healthcare infrastructure, particularly in emerging economies, has further fueled market growth. Improved healthcare facilities, a greater number of skilled medical professionals, and increased healthcare expenditures have enhanced access to advanced medical treatments, including shoulder replacement surgeries.

How the High Cost of Shoulder Replacement Surgery and the Risk of Infection, and Blood Clots is Impeding the Growth of the Shoulder Replacement Market?

Shoulder replacement surgery is an expensive procedure, encompassing costs beyond just the implant itself. Patients face substantial expenses related to hospital stays, surgeon fees, rehabilitation, and pain medication, which can pose a significant financial burden, particularly for those with limited insurance coverage. For instance, in Hyderabad, the average cost of shoulder replacement surgery generally ranges from ₹3 lakhs to ₹8 lakhs. This variation in cost depends on several factors, including the type of procedure, the severity of the condition, the quality of hospital amenities, and the proficiency of the surgeon. Despite the potential benefits, the inherent risks and complications associated with any surgery, including shoulder replacement, can deter some patients. These risks include infection, blood clots, nerve damage, and implant loosening, which can compromise the surgery's success and lead to further medical interventions.

Additionally, while shoulder replacement surgery has demonstrated positive outcomes in many cases, the availability of long-term data on implant durability and the effectiveness of various surgical techniques remains limited. This lack of comprehensive long-term evidence can create uncertainty for both patients and surgeons, influencing the decision-making process. Moreover, shoulder replacement is not suitable for everyone. Factors such as age, overall health, and the severity of joint damage play a critical role in determining candidacy for the procedure, thereby limiting the potential market size.

Non-surgical alternatives, such as pain management, physical therapy, and cortisone injections, offer relief for some patients experiencing shoulder pain. These options can delay or, in some cases, eliminate the need for surgical intervention, further impacting the demand for shoulder replacement surgery. Furthermore, the success of shoulder replacement surgery heavily depends on a rigorous rehabilitation program. Following the procedure, patients must commit to dedicated physical therapy to regain strength, mobility, and range of motion. This requirement for extensive rehabilitation can be a significant hurdle, particularly for those who may struggle with the commitment or face barriers to accessing consistent physical therapy.

Category-Wise Acumens

How the Degenerative Joint Diseases of Shoulder and Advancements in Implants are Surging the Growth of the Anatomic Shoulder Replacement Segment?

Anatomic Shoulder Replacement is showing significant growth in the Shoulder Replacement Market. Arthroplasty has proven to be one of the most reliable treatment options for degenerative joint diseases of the shoulder. Over the past 60 years, there have been significant advancements in implant designs to address initial challenges in arthroplasty, such as restoring function and preventing implant loosening. For instance, according to

the University of North Carolina

report among individuals with osteoarthritis (OA), 43% are aged 65 or older, and 88% are aged 45 or older. The annual incidence of knee OA is highest among those aged 55 to 64. Notably, more than half of individuals with symptomatic knee OA are younger than 65.

Despite the rise of reverse shoulder arthroplasty (RSA) as the most commonly performed type of shoulder replacement in major countries like the United States and the United Kingdom, total anatomical shoulder arthroplasty (TSA) remains a well-established treatment for osteoarthritis in patients with a competent rotator cuff. Patients with osteoarthritis who undergo TSA now expect lasting and significant improvements in pain and function. The demonstrated efficacy of anatomical shoulder arthroplasty suggests that it will gain more attention in the future.

How the Increasing Demand for Surgery's effectiveness Fostering the Growth of the Reverse Shoulder Arthroplasty Segment?

The Reverse Shoulder Arthroplasty (RSA) segment has emerged as the dominant force in the Shoulder Replacement Market. This rise in popularity is attributed to the surgery's effectiveness and its ability to preserve the deltoid muscle, which is crucial for shoulder function. RSA utilizes a specific class of artificial joints designed to restore function to shoulders that have been severely damaged. These prostheses consist of three main components: a stem that is inserted into the humerus bone, a glenoid or socket, and an upper arm component. Unlike anatomic shoulder replacements, where the ball joint is positioned behind the shoulder, RSA places the ball joint above the shoulder. This unique design significantly enhances the stability of the shoulder and provides a wider range of motion for the arm, making it a preferred choice for patients with severe shoulder issues. The ability of RSA to improve functionality and mobility in patients who might otherwise have limited options has solidified its position as a leading treatment in shoulder arthroplasty.

Country/Region-wise Acumens

How the Robust Infrastructure and Sophisticated Surgical Procedures are Surging the Growth of the Shoulder Replacement Market in North America?

The North American region leads the Shoulder Replacement Market and is projected to maintain its dominance throughout the forecast period. This leadership is driven by the presence of major international companies within the medical device industry, positioning the United States and Canada as key hotspots for medical innovation and development. The advanced healthcare systems in these countries further fuel market growth by providing the infrastructure necessary to support sophisticated surgical procedures.

The rising healthcare expenditure in North America. Both the United States and Canada allocate a substantial portion of their GDP to healthcare, facilitating greater investment in advanced medical technologies such as joint replacements. This financial commitment enables the adoption of cutting-edge implants and surgical techniques, enhancing the overall quality and accessibility of shoulder replacement procedures.

Moreover, the emphasis on maintaining active lifestyles across North America, even into older age, has increased the demand for shoulder replacement surgeries. Many individuals prioritize mobility and physical activity, and shoulder replacement surgery allows them to regain function and engage in their desired activities. This focus on active living drives the adoption of surgical interventions to treat debilitating shoulder conditions.

Technological advancements also play a crucial role in the growth of the shoulder replacement market in North America. Continuous innovations in implant design, the development of minimally invasive surgical techniques, and improvements in pain management protocols significantly enhance surgical outcomes and patient recovery. These advancements make shoulder replacement surgery a more attractive and viable option for patients, thereby boosting market growth.

How the Rising Healthcare Expenditures and Increasing Geriatric Population is Escalating the Growth of Shoulder Replacement Market in Asia Pacific?

Asia Pacific is emerging as the fastest-growing region in the Shoulder Replacement Market, fueled by increased healthcare spending and favorable demographic trends. The region's rising healthcare expenditures are translating into significant growth opportunities for both multinational corporations (MNCs) and local medical device players. This trend is supported by an aging population and rising disposable incomes, which have transformed the Asia Pacific into a burgeoning hub for various industries, particularly healthcare.

Moreover, the region's attractiveness is amplified by the growing trend of medical tourism, driven by lower treatment costs compared to Western countries and supportive government regulations that incentivize domestic companies. This environment has enhanced the appeal of Asia Pacific as a lucrative market for shoulder replacement surgeries, particularly in the category of implant types.

The increasing prevalence of chronic diseases and musculoskeletal disorders among the aging population has heightened the demand for advanced orthopedic treatments like shoulder replacements across the Asia Pacific. As healthcare infrastructure continues to develop and regulatory frameworks evolve to support innovation, foreign investments in the region's medical device sector are expected to expand further.

Competitive Landscape

The shoulder replacement market is a dynamic space driven by innovation, value-based care, and strategic partnerships. While major medical device companies hold a dominant position, emerging players with niche solutions and a focus on cost-effectiveness can carve out a space in this competitive landscape.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the shoulder replacement market include:

• Johnson & Johnson
• Stryker Corporation
• Zimmer Biomet
• Exactech
• Waldemar Link GmbH & Co. KG
• Arthrex, Inc.
• Aesculap AG (a subsidiary of B. Braun SE)
• DJO Global, Inc.
• Osteonics Corporation
• Shoulder Replacement Market Latest Developments
• In August 2021, Smith Nephew announced the launch of new total ankle and total shoulder replacement technologies as well as showcase its freshly enlarged extremities portfolio during the American Academy of Orthopaedic Surgeons' 2021 Annual Meeting in San Diego.
• In July 2021, Stryker's Tornier shoulder arthroplasty portfolio was announced, together with the Tornier Perform Humeral System.
• In March 2023, Geisinger Health Plan and Medacta Group SA, a Swiss business that specializes in sustainable joint replacement, sports medicine, and spine treatments, announced the first-ever lifetime guarantee for a lumbar spinal fusion procedure.
• In August 2021, The American Academy of Orthopedic Surgeons' 2021 Annual Meeting will be held in San Diego. Smith Nephew will display its newly expanded extremities range, as well as innovative ankle and shoulder replacement technologies.
• In August 2021, Johnson and Johnson revealed the ENHANCE Shoulder System, a fully integrated shoulder arthroplasty system. It enables doctors to simply swap between stemless and stemmed implants during surgical procedures.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Shoulder Replacement Market, By Procedure Type

• Total Shoulder Arthroplasty (TSA)
• Partial Shoulder Arthroplasty (Hemiarthroplasty)

5. Shoulder Replacement Market, By Implant Design

• Anatomic Shoulder Replacement
• Reverse Shoulder Replacement

6. Shoulder Replacement Market, By Implant Material

• Metal Implants
• Polyethylene Implants

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Johnson & Johnson
• Stryker Corporation
• Zimmer Biomet
• Exactech
• Waldemar Link GmbH & Co. KG
• Arthrex, Inc.
• Aesculap AG (subsidiary of B. Braun SE)
• DJO Global, Inc.
• Osteonics Corporation

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References